Stay updated on Autologous DCs+Tumor Lysate+Nivolumab in Recurrent Glioblastoma Clinical Trial

Sign up to get notified when there's something new on the Autologous DCs+Tumor Lysate+Nivolumab in Recurrent Glioblastoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Autologous DCs+Tumor Lysate+Nivolumab in Recurrent Glioblastoma Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    Change Detected
    Summary
    Revision updated from v3.4.3 to v3.5.0.
    Difference
    0.1%
    Check dated 2026-03-21T00:56:04.000Z thumbnail image
  4. Check
    24 days ago
    No Change Detected
  5. Check
    31 days ago
    Change Detected
    Summary
    Page revision label updated from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-06T17:46:01.000Z thumbnail image
  6. Check
    53 days ago
    Change Detected
    Summary
    A minor revision tag was updated from v3.4.1 to v3.4.2, with no substantive changes to study content or page elements. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-12T20:44:34.000Z thumbnail image
  7. Check
    61 days ago
    Change Detected
    Summary
    Revision label updated from v3.4.0 to v3.4.1. This is a minor metadata update that does not affect study details or user interactions; To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-05T11:27:28.000Z thumbnail image
  8. Check
    68 days ago
    Change Detected
    Summary
    The page shows minor UI and metadata updates: a new 'Show glossary' option appears, capitalization variations for 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data' are adjusted, and the revision tag updated to v3.4.0 from v3.3.4. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-01-29T06:32:52.000Z thumbnail image
  9. Check
    82 days ago
    Change Detected
    Summary
    Revision label updated from v3.3.3 to v3.3.4 on the page, indicating a technical update with no changes to study content or eligibility criteria. No study data or interactions were modified. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-15T03:06:22.000Z thumbnail image

Stay in the know with updates to Autologous DCs+Tumor Lysate+Nivolumab in Recurrent Glioblastoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Autologous DCs+Tumor Lysate+Nivolumab in Recurrent Glioblastoma Clinical Trial page.